LEADER 01602nam 2200385Ia 450 001 996393498603316 005 20221108091320.0 035 $a(CKB)3450000000104269 035 $a(EEBO)2240942409 035 $a(UnM)9929064300971 035 $a(UnM)99897507 035 $a(EXLCZ)993450000000104269 100 $a19990112d1696 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 12$aA letter from a member of the parliament of Scotland to his friend at London, concerning their late act, for establishing a company of that kingdom, tradeing to Africa and the Indies$b[electronic resource] 210 $a[[Edinburgh] $cPrinted at London, and re-printed at Edinburgh, by the heirs and successors of Andrew Anderson, printer to the King's most excellent Majesty$d1696] 215 $a19, [1] p 300 $aSigned at end: Philonax Verax. 300 $aCaption title. 300 $aImprint from colophon. 300 $aReproduction of original in the John Carter Brown Library. 330 $aeebo-0114 606 $aTrading companies$zScotland$vEarly works to 1800 606 $aTrading companies$zEngland$vEarly works to 1800 615 0$aTrading companies 615 0$aTrading companies 700 $aVerax$b Philanax$01004841 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bWaOLN 906 $aBOOK 912 $a996393498603316 996 $aA letter from a member of the parliament of Scotland to his friend at London, concerning their late act, for establishing a company of that kingdom, tradeing to Africa and the Indies$92316649 997 $aUNISA LEADER 02502nam 2200577 450 001 9910797122503321 005 20230807215829.0 010 $a0-19-936879-1 010 $a0-19-936880-5 010 $a0-19-936878-3 035 $a(CKB)3710000000422722 035 $a(EBL)2068361 035 $a(OCoLC)910935514 035 $a(SSID)ssj0001499993 035 $a(PQKBManifestationID)12535896 035 $a(PQKBTitleCode)TC0001499993 035 $a(PQKBWorkID)11516750 035 $a(PQKB)11701228 035 $a(MiAaPQ)EBC2068361 035 $a(StDuBDS)EDZ0001192926 035 $a(Au-PeEL)EBL2068361 035 $a(CaPaEBR)ebr11064024 035 $a(CaONFJC)MIL798068 035 $a(EXLCZ)993710000000422722 100 $a20150619h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aManaging disruptive change in healthcare $elessons from a public-private partnership to advance cancer care and research /$fArnold D. Kaluzny and Donna M. O'Brien 210 1$aNew York, New York :$cOxford University Press,$d2015. 210 4$dİ2015 215 $a1 online resource (353 p.) 300 $aDescription based upon print version of record. 311 $a0-19-936877-5 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $a""Acknowledgments""""Glossary of Terms and Acronyms""; ""About the Contributing Authors""; ""Name Index""; ""Subject Index"" 330 $aHealthcare faces unprecedented global challenges. Rapid advances in genomics, computational sciences, and technology -- as well as the new focus on value-based care and an increased trend toward healthcare commercialization -- represent disruptive changes to an already-fragmented delivery system. The healthcare establishment has been slow to adapt, and now faces rising cancer-care costs and lags in outcome improvement and genomically informed interventions. Managing Disruptive Change in Healthcare codifies the US National Cancer Institute's lessons from utilizing a public-private partnership w 606 $aMedical care$zUnited States 615 0$aMedical care 676 $a362.19699/4 700 $aKaluzny$b Arnold D.$01538763 702 $aO'Brien$b Donna M. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797122503321 996 $aManaging disruptive change in healthcare$93789076 997 $aUNINA